Trilostane therapy for hyperadrenocorticism in three dogs with adrenocortical metastasis
| Autor: | E. Gomez, G. Benchekroun, R. Moraillon, P De Fornel-Thibaud, Dominique Begon, Françoise Delisle, S. Lafarge, D. Héripret, C. Maurey, D. Rosenberg |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Surgical resection
medicine.medical_specialty Adrenocortical Hyperfunction Lung Neoplasms General Veterinary business.industry Urology Retrospective cohort study Trilostane Dihydrotestosterone General Medicine Adrenal tumours medicine.disease Adrenal Cortex Neoplasms Metastasis Endocrinology Dogs Internal medicine medicine Animals business medicine.drug Retrospective Studies |
| Zdroj: | The Veterinary record. 163(6) |
| ISSN: | 0042-4900 |
| Popis: | IN dogs, more than half of the adrenal tumours responsible for hyperadrenocorticism are malignant ([Reusch and Feldman 1991][1]). They can be metastasised by the time of diagnosis or after surgical resection. Medical management is therefore required to control the clinical signs. Trilostane is an |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text